Home | Welcome to Contract Pharma   
Last Updated Saturday, October 25 2014
Print

Search Results for 'Financial Report: Charles River Laboratories'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published August 7, 2014
Manufacturing revenue up 18% in the quarter Read More »
By Kristin Brooks
Published February 25, 2014
Q&A with Birgit Girshick about the insourcing/outsourcing service for pharma and biopharma Read More »
By Kristin Brooks
Published February 12, 2014
PCS segment sales up 8% in the quarter Read More »
Published September 27, 2013
Crowley to provide strategic guidance to the finance groups Read More »
Published August 1, 2013
Revenues up 3% in the quarter Read More »
Published February 14, 2013
Revenues decline 4% in the quarter Read More »
Charles River Laboratories
By Customer Service
Charles River provides products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions accelerate their research and drug development efforts. We are focused on providing clients with ex… Read More »
By Gil Y. Roth
Published June 6, 2011
Managing preclinical operations Read More »
Published August 5, 2009
Sales declined in both the Research Models and Services (RMS) and Preclinical Services (PCS) segments, reflecting the negative impact of foreign exchange, as well as softer market demand. Read More »
Published May 10, 2006
Kendle will acquire the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. for approximately $215 million in cash. The move will strengthen Kendle's position in the clinical development industry, adding therapeut… Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On